HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroaki Tanaka Selected Research

C-Reactive Protein

1/2022Prognostic impact of postoperative systemic inflammatory response in patients with stage II/III gastric cancer.
9/2021Preoperative C-reactive protein to albumin ratio predicts anastomotic leakage after esophagectomy for thoracic esophageal cancer: a single-center retrospective cohort study.
6/2020Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer.
8/2019C-reactive protein elevation ratio as an early predictor of postoperative severe complications after laparoscopic gastrectomy for gastric cancer: a retrospective study.
6/2018Comparison of the prognostic impact and combination of preoperative inflammation-based and/or nutritional markers in patients with stage II gastric cancer.
3/2017C-Reactive Protein Indicates Early Stage of Postoperative Infectious Complications in Patients Following Minimally Invasive Esophagectomy.
9/2015Significance of Markers of Systemic Inflammation for Predicting Survival and Chemotherapeutic Outcomes and Monitoring Tumor Progression in Patients with Unresectable Metastatic Colorectal Cancer.
11/2014Elevated preoperative serum C-reactive protein levels are associated with poor survival in patients with colorectal cancer.
1/2014Gastric metastasis from renal cell carcinoma with gastrointestinal bleeding: a case report and review of the literature.
11/2013[Five cases of severe radiation pneumonitis after chemoradiotherapy for esophageal cancer].
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroaki Tanaka Research Topics

Disease

98Neoplasms (Cancer)
03/2024 - 06/2002
57Stomach Neoplasms (Stomach Cancer)
11/2023 - 11/2002
30Neoplasm Metastasis (Metastasis)
03/2023 - 11/2002
24Fetal Growth Retardation (Intrauterine Growth Retardation)
12/2023 - 09/2016
22Breast Neoplasms (Breast Cancer)
11/2023 - 01/2013
19Esophageal Neoplasms (Esophageal Cancer)
11/2023 - 11/2009
15Colorectal Neoplasms (Colorectal Cancer)
09/2023 - 11/2009
11Hemorrhage
01/2022 - 11/2013
10Inflammation (Inflammations)
03/2024 - 12/2006
9Infections
12/2023 - 08/2007
9Rectal Neoplasms (Rectal Cancer)
12/2023 - 11/2010
9Lymphatic Metastasis
03/2023 - 11/2002
9Human Influenza (Influenza)
08/2022 - 06/2009
9Carcinoma (Carcinomatosis)
11/2021 - 11/2002
9Obesity
10/2021 - 06/2004
9Insulin Resistance
01/2021 - 10/2002
9Lymphoma (Lymphomas)
12/2018 - 01/2012
9Pancreatic Neoplasms (Pancreatic Cancer)
08/2017 - 12/2005
8Esophageal Squamous Cell Carcinoma
06/2022 - 07/2012
8Pre-Eclampsia (Preeclampsia)
01/2022 - 07/2017
7Hepatocellular Carcinoma (Hepatoma)
01/2015 - 04/2006
6Disease Progression
08/2022 - 10/2014
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 05/2016
5Heart Failure
05/2024 - 06/2014
5Hypoxia (Hypoxemia)
02/2023 - 01/2013
5Multiple Myeloma
09/2022 - 03/2008
5Cardiovascular Diseases (Cardiovascular Disease)
08/2019 - 02/2008
4Maternal Death
04/2024 - 01/2015
4Stroke (Strokes)
03/2024 - 01/2011
4COVID-19
12/2023 - 12/2021
4Pneumonia (Pneumonitis)
01/2023 - 01/2021
4Anastomotic Leak
09/2021 - 05/2014
4Leukemia
02/2021 - 11/2012
4Fever (Fevers)
05/2020 - 04/2008
4Hypertension (High Blood Pressure)
01/2018 - 01/2009
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2014 - 11/2009
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
07/2023 - 04/2013
3Vascular Remodeling
02/2023 - 01/2017
3Sarcopenia
01/2023 - 02/2019

Drug/Important Bio-Agent (IBA)

24Tadalafil (Cialis)FDA Link
01/2024 - 11/2016
17Biomarkers (Surrogate Marker)IBA
10/2023 - 01/2013
13Proteins (Proteins, Gene)FDA Link
11/2023 - 10/2002
11C-Reactive ProteinIBA
01/2022 - 08/2007
10CytokinesIBA
03/2024 - 09/2003
10Glucose (Dextrose)FDA LinkGeneric
01/2021 - 10/2002
9Indicators and Reagents (Reagents)IBA
11/2023 - 07/2014
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2023 - 12/2005
8Hormones (Hormone)IBA
02/2023 - 01/2009
8AntigensIBA
03/2021 - 03/2011
7ErbB Receptors (EGF Receptor)IBA
01/2023 - 10/2014
7Fluorouracil (Carac)FDA LinkGeneric
03/2021 - 11/2009
7EnzymesIBA
05/2020 - 09/2008
7Oseltamivir (Tamiflu)FDA Link
07/2015 - 06/2009
6VaccinesIBA
08/2022 - 04/2011
6Insulin (Novolin)FDA Link
12/2018 - 02/2004
6Peptides (Polypeptides)IBA
01/2017 - 04/2011
6oseltamivir carboxylateIBA
07/2015 - 01/2010
5Immune Checkpoint InhibitorsIBA
11/2023 - 12/2019
5Bevacizumab (Avastin)FDA Link
02/2023 - 11/2011
5Prednisolone (Predate)FDA LinkGeneric
09/2021 - 11/2008
5Tyrosine Kinase InhibitorsIBA
01/2021 - 04/2014
5Immunoglobulin M (IgM)IBA
02/2019 - 02/2010
5Eosine Yellowish-(YS) (Eosin)IBA
12/2018 - 10/2013
5Hematoxylin (Haematoxylon)IBA
12/2018 - 10/2013
5HLA-A Antigens (HLA-A)IBA
01/2017 - 04/2011
4Phosphodiesterase 5 InhibitorsIBA
11/2023 - 12/2017
4Paclitaxel (Taxol)FDA LinkGeneric
02/2023 - 11/2012
4Transforming Growth Factors (Transforming Growth Factor)IBA
01/2023 - 11/2010
4Therapeutic UsesIBA
08/2022 - 01/2021
4Anti-Bacterial Agents (Antibiotics)IBA
05/2022 - 07/2017
4NG-Nitroarginine Methyl Ester (L-NAME)IBA
01/2022 - 12/2017
4AlbuminsIBA
09/2021 - 06/2018
4Rituximab (Mabthera)FDA Link
08/2021 - 01/2012
4Messenger RNA (mRNA)IBA
01/2018 - 08/2009
4Zanamivir (Relenza)FDA Link
07/2015 - 12/2012
4Oxygen (Dioxygen)IBA
02/2015 - 01/2002
4Amantadine (Aman)FDA LinkGeneric
11/2013 - 09/2010
4nedaplatinIBA
11/2013 - 11/2009
3RNA (Ribonucleic Acid)IBA
12/2023 - 05/2010
3Tumor Biomarkers (Tumor Markers)IBA
12/2023 - 01/2013
3eribulinFDA Link
02/2023 - 11/2021
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2022 - 09/2019

Therapy/Procedure

79Therapeutics
11/2023 - 11/2002
47Drug Therapy (Chemotherapy)
03/2023 - 11/2009
24Gastrectomy
11/2023 - 01/2007
16Esophagectomy
11/2023 - 02/2013
14Neoadjuvant Therapy
12/2023 - 11/2011
10Lymph Node Excision (Lymph Node Dissection)
12/2023 - 06/2009
8Chemoradiotherapy
11/2017 - 11/2009
7Adjuvant Chemotherapy
12/2023 - 11/2009
7Cesarean Section (Caesarean Section)
08/2023 - 11/2013
6Stem Cell Transplantation
09/2022 - 01/2012
6Laparotomy
02/2019 - 06/2009
5Combination Drug Therapy (Combination Chemotherapy)
02/2023 - 06/2007
5Immunotherapy
06/2022 - 12/2003
5Aftercare (After-Treatment)
01/2019 - 01/2013
4Hysterectomy
08/2023 - 12/2016
4Length of Stay
10/2022 - 11/2013
4Hematopoietic Stem Cell Transplantation
11/2017 - 08/2007
4Radiotherapy
11/2014 - 11/2009